The function of partially exhausted CD8 + T cells could be partially rescued by immune checkpoint blockers, such as anti-PD1 or anti-PDL1 antibodies, which is currently one of the treatment strategies for cancer [7]. The gene discussed is PDCD1; the disease is cancer.